Analysts at Leerink Swann upgraded Boston Scientific stock from “market perform” to “outperform.” Leerink Swann has an $18 price target on the company’s stock, according to a WKRB News & Analysis report.
Boston Scientific disclosed insider trading activity — David A. Pierce, senior vice president and president, endoscopy of Boston Scientific unloaded 5,000 shares at an average price of $12.90.
EndoChoice fulfilled customer orders for its newly-released second generation Fuse system.
Medigus has been awarded a Japanese patent for its miniature camera — the micro ScoutCam.
Pharmaceutical company Roche received FDA approval for the cobas TaqScreen MPX Test, v2.0. The test can be used in the detection and identification of HIV, Hepatitis C virus and Hepatitis B virus in human blood.
In the wake of its AbbVie deal fall through, Shire has agreed to acquire NPS Pharmaceuticals, according to a report by The New York Times.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
GI physician social media preferences: Facebook vs. Twitter
7 New Year’s resolutions from the AGA
Dr. Michelle Inkster named Professional Woman of the Year
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
